Benefiting global patients with high quality Chinese biologics is our supreme goal
Since 1993, 3SBio always regards product quality as the lifeline of the enterprise. So far, we have a wealth of product series under study, with more than 30 listed products, 32 kinds of alternative products, among which 22 serve as National New Drugs.
1993
我们的主要运营附属公司沈阳尊龙凯时于中国成立。
1995
我们的注射用重组人干扰素α-2a产品因特芬推出。
1996
我们的重组人白介素2产品英路因推出，为首只引入中国市场的白介素产品之一。
1997
我们的核心产品重组人促红素注射液益比奥在中国推出。